What does Pharma Force do?

Pharma Force is a pharmacy in Gent. Public Limited, started on 8 July 2003, 4 establishments.

What is the address of Pharma Force?

The registered office of Pharma Force is located at Poortakkerstraat 41G, 9051 Gent.

Is Pharma Force still active?

Yes. According to the CBE (30 October 2026) Pharma Force is active, legal situation “Normale toestand”, started on 8 July 2003.

Is Pharma Force registered on Peppol?

Yes, Pharma Force is registered on the Peppol network with ID 0208:0859585888.

What is the enterprise number of Pharma Force?

The enterprise number of Pharma Force is BE0859585888.

When was Pharma Force founded?

Pharma Force was founded on 8 July 2003.

Who are the directors of Pharma Force?

According to the 2024 annual accounts, the directors of Pharma Force are: Peeters Mathieu Management BV.

Is Pharma Force a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 July 2003; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account; 4 establishments in the CBE.

How much profit did Pharma Force make in 2024?

Pharma Force posted a profit after taxes of € 1,929,557 in financial year 2024.

What is the revenue of Pharma Force?

In its most recent annual accounts (2024), Pharma Force reported revenue of € 23,129,723.

How much does an employee at Pharma Force earn?

The average wage cost per full-time employee at Pharma Force was € 46,100 in 2024: staff costs of € 4.9 million for 105.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Pharma Force have?

According to the 2024 annual accounts, Pharma Force has 105.4 full-time equivalents (FTE).

Does Pharma Force have a website?

Yes, Pharma Force has a website at pharmaforce.be.

Pharma Force (Public Limited) - Gent - BE0859585888

Dossier Pharma Force, printed on 30 October 2026 from databakkes.be/en/0859585888/pharma-force. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

Pharma Force from Gent, company number BE0859585888, closed financial year 2024 with a result of € 1.9 million after tax. For that financial year Pharma Force recorded revenue of € 23.1 million and equity of € 11.2 million. Compared with financial year 2023, the result moved from € 2.2 million to € 1.9 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2025.

What it is worth Growing

€ 11.2 million

▲ 21% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 1.9 million

▼ 13% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 140,909

▼ 2% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € -13.1 million.

People and assets in 2024

Full-time equivalents

105.4

▼ 0.7 vs 2023

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 3.5 million in 2024, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 4.9 million

€ 46,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 721,427

▼ 12% vs 2023

Of which on lease € 284,061.

Debts at end 2024

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.5 million

▲ 32% vs 2023

€ 215,487 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 2.1 million

▼ 25% vs 2023

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 42 days on average.

Taxes and wages

€ 871,791

▼ 18% vs 2023

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Revenue	€ 25,645,528 Revenue 2021: € 25,645,528 First fiscal year in the series	€ 23,826,577 Revenue 2022: € 23,826,577 ▼ 7% vs 2021 (€ 25,645,528) Unfavourable step	€ 24,406,503 Revenue 2023: € 24,406,503 ▲ 2% vs 2022 (€ 23,826,577) Favourable step	€ 23,129,723 Revenue 2024: € 23,129,723 ▼ 5% vs 2023 (€ 24,406,503) Unfavourable step	▼ 5%
Profit after taxes	€ 4,255,985 Profit after taxes 2021: € 4,255,985 First fiscal year in the series	€ 2,841,367 Profit after taxes 2022: € 2,841,367 ▼ 33% vs 2021 (€ 4,255,985) Unfavourable step	€ 2,215,671 Profit after taxes 2023: € 2,215,671 ▼ 22% vs 2022 (€ 2,841,367) Unfavourable step	€ 1,929,557 Profit after taxes 2024: € 1,929,557 ▼ 13% vs 2023 (€ 2,215,671) Unfavourable step	▼ 13%
Equity	€ 4,254,175 Equity 2021: € 4,254,175 First fiscal year in the series	€ 7,095,542 Equity 2022: € 7,095,542 ▲ 67% vs 2021 (€ 4,254,175) Favourable step	€ 9,311,213 Equity 2023: € 9,311,213 ▲ 31% vs 2022 (€ 7,095,542) Favourable step	€ 11,240,770 Equity 2024: € 11,240,770 ▲ 21% vs 2023 (€ 9,311,213) Favourable step	▲ 21%
Total debts	€ 9,916,761 Total debts 2021: € 9,916,761 First fiscal year in the series	€ 8,196,100 Total debts 2022: € 8,196,100 ▼ 17% vs 2021 (€ 9,916,761) Favourable step	€ 5,017,746 Total debts 2023: € 5,017,746 ▼ 39% vs 2022 (€ 8,196,100) Favourable step	€ 4,508,125 Total debts 2024: € 4,508,125 ▼ 10% vs 2023 (€ 5,017,746) Favourable step	▼ 10%
Cash	€ 349,072 Cash 2021: € 349,072 First fiscal year in the series	€ 266,698 Cash 2022: € 266,698 ▼ 24% vs 2021 (€ 349,072) Unfavourable step	€ 143,867 Cash 2023: € 143,867 ▼ 46% vs 2022 (€ 266,698) Unfavourable step	€ 140,909 Cash 2024: € 140,909 ▼ 2% vs 2023 (€ 143,867) Unfavourable step	▼ 2%
Retained profit	€ -20,116,481 Retained profit 2021: € -20,116,481 First fiscal year in the series	€ -17,275,114 Retained profit 2022: € -17,275,114 ▲ € 2.8 million vs 2021 (€ -20,116,481) Favourable step	€ -15,059,443 Retained profit 2023: € -15,059,443 ▲ € 2.2 million vs 2022 (€ -17,275,114) Favourable step	€ -13,129,886 Retained profit 2024: € -13,129,886 ▲ € 1.9 million vs 2023 (€ -15,059,443) Favourable step	▲ € 1.9 million
Bank debt	€ 1,934,218 Bank debt 2021: € 1,934,218 First fiscal year in the series	€ 991,871 Bank debt 2022: € 991,871 ▼ 49% vs 2021 (€ 1,934,218) Favourable step	€ 1,172,797 Bank debt 2023: € 1,172,797 ▲ 18% vs 2022 (€ 991,871) Unfavourable step	€ 1,548,872 Bank debt 2024: € 1,548,872 ▲ 32% vs 2023 (€ 1,172,797) Unfavourable step	▲ 32%
Balance sheet total	€ 14,170,936 Balance sheet total 2021: € 14,170,936 First fiscal year in the series	€ 15,291,642 Balance sheet total 2022: € 15,291,642 ▲ 8% vs 2021 (€ 14,170,936) Unchanged	€ 14,328,959 Balance sheet total 2023: € 14,328,959 ▼ 6% vs 2022 (€ 15,291,642) Unchanged	€ 15,748,895 Balance sheet total 2024: € 15,748,895 ▲ 10% vs 2023 (€ 14,328,959) Unchanged	▲ 10%
Employees (FTE)	113 Employees (FTE) 2021: 113 First fiscal year in the series	106.5 Employees (FTE) 2022: 106.5 ▼ 6.5 vs 2021 (113) Unchanged	106.1 Employees (FTE) 2023: 106.1 ▼ 0.4 vs 2022 (106.5) Unchanged	105.4 Employees (FTE) 2024: 105.4 ▼ 0.7 vs 2023 (106.1) Unchanged	▼ 0.7

Key figures of Pharma Force, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Pharma Force?

What happened at Pharma Force in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 23, 2025 New annual accounts for financial year 2024: profit of € 1.9 million (▼ 13% vs 2023). Source: NBB ↗
2019 Peeters Mathieu Management BV became a director. NBB
Nov 16, 2015 New establishment in Gent. KBO
Jan 1, 2007 New establishment in Antwerpen. KBO
Nov 4, 2003 New establishment in Liège. KBO
Jul 8, 2003 New establishment in Sint-Gillis (bij-Brussel). KBO
Jul 8, 2003 Start of the company according to the CBE. KBO

In short

From € 4.3 million profit in 2021 to € 1.9 million profit in 2024.

Paid € 787,044 in corporate taxes since 2021.

Best year ever: 2021, with € 4.3 million profit.

Pays suppliers within 42 days on average.

Original PDFs at the National Bank ↗

Management

peeters mathieu management 100%

The stake of peeters mathieu management comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Pharma Force

Behind Pharma Force is Peeters Mathieu Management BV. The shares are held by peeters mathieu management (100%).

Directors

According to the 2024 annual accounts

Peeters Mathieu Management BV

Managing director · represented by Mathieu Peeters

Also active at: APOTHEEK PEETERS - PETIT, PHARMA BASE, PEETERS PHARMA

since 2019

Shareholders

peeters mathieu management

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Poortakkerstraat 41G

9051 Gent

2.135.960.388

Henri Jasparlaan 138

1060 Sint-Gillis (bij-Brussel)

Active since 8 July 2003

2.143.088.504

Quai de Rome 49c

4000 Liège

Active since 4 November 2003

2.168.310.779

Kloosterstraat 80

2180 Antwerpen

Active since 1 January 2007

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS pharmaforce.be

Canonical: https://www.pharmaforce.be/

Technologies

Anime.jsFlickityLightboxNginxPHPSwiperWPBakeryWordPressYoast SEOjQuery

Hosting & Email

Email provider

Self-hosted

Hosting

COMBELL-AS, BE

Website info

HTTPS Ja

Languages NL

Features

Webshop Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number

0859.585.888

VAT number

BE 0859.585.888

Registered office

Poortakkerstraat 41G, 9051 Gent

Names & denominations

Pharma Force

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

8 July 2003

Peppol

Active · Active since 24 Jun 2025

Contact

pharmaforce.be [email protected] 092151812

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Pharma Force

Financials

What happened to Pharma Force?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Hosting & Email

Website info

Features

Security

Details

Frequently asked questions